Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on September 2, 2026

Supernus Pharmaceuticals to Participate in September Investor Conferences
SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company
Inventiva Announces Last Patient Visit in NATiV3 Phase 3 Clinical Trial of Lanifibranor in MASH
Inventiva annonce la dernière visite du dernier patient de l’étude clinique de Phase 3 NATiV3 évaluant le lanifibranor dans la MASH
Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
nCino to Participate in Upcoming Investor Event 
Surrozen to Present at Upcoming Healthcare Investor Conferences
Kyverna Therapeutics to Present at Upcoming Investor Conferences
Shattuck Labs Announces Participation in Upcoming September Investor Conferences
Netskope Announces Strong Second Quarter Fiscal 2027 Financial Results
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
SPS Commerce to Present at Citi's 2026 Global TMT Conference
Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Technijian Unveils the Jian AI Agent Family and Expands AI Services
Aura Biosciences to Participate in Upcoming Investor Conference
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
Black Diamond Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.